Methods and compositions relating to the treatment of cancer
US-2015374692-A1 · Dec 31, 2015 · US
US2016367698A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016367698-A1 |
| Application number | US-201615170428-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 1, 2016 |
| Priority date | Sep 3, 2014 |
| Publication date | Dec 22, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepine compounds of formula (I)-(VII). The invention also provides conjugates of the benzodiazepine compounds linked to a cell-binding agent. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention.
Opening claim text (preview).
1 . A compound represented by any one of the following formulas: or a pharmaceutically acceptable salt thereof, wherein: the double line between N and C represents a single bond or a double bond, provided that when it is a double bond, X is absent and Y is —H, and when it is a single bond, X is selected from —H; Y is —H, —SO 3 M or —OH wherein M is —H or a cation; X′ is —H; Y′ is —H…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.